Your browser doesn't support javascript.
loading
Viral interference during influenza A-SARS-CoV-2 coinfection of the human airway epithelium and reversal by oseltamivir.
Cheemarla, Nagarjuna R; Watkins, Timothy A; Mihaylova, Valia T; Foxman, Ellen F.
Affiliation
  • Cheemarla NR; Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT, USA 06520.
  • Watkins TA; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA 06520.
  • Mihaylova VT; Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT, USA 06520.
  • Foxman EF; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA 06520.
J Infect Dis ; 2023 Sep 18.
Article in En | MEDLINE | ID: mdl-37722683
ABSTRACT
To gain insight into interactions among respiratory viruses, we modeled influenza A virus (IAV) - SARS-CoV-2 coinfections using differentiated human airway epithelial cultures. Replicating IAV induced a more robust interferon response than SARS-CoV-2 and suppressed SARS-CoV-2 replication in both sequential and simultaneous infections, whereas SARS-CoV-2 did not enhance host cell defense during influenza infection or suppress IAV replication. Oseltamivir, an antiviral targeting influenza, reduced IAV replication during coinfection but also reduced the host antiviral response and restored SARS-CoV-2 replication. These results demonstrate how perturbations in one viral infection can impact its effect on a coinfecting virus.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Infect Dis Year: 2023 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Infect Dis Year: 2023 Type: Article